Press Releases

23 Apr 2026

­­­­­­­­­Dual-pathway blockade therapy offers hope for rare, hard-to-treat gynaecological clear cell cancers

The LARA trial explored a dual‑pathway approach: Lenvatinib was used to block signals that support tumour growth and blood‑vessel formation, while also helping to make the tumour environment more accessible to immune cells; Pembrolizumab then boosted the body’s immune response to recognise and attack cancer cells.

22 Apr 2026

New tele-dentistry programme supports early intervention for children at risk of caries

The tele-dentistry programme brings together the clinical, academic and public health expertise from the National University Hospital (NUH), the Faculty of Dentistry, National University of Singapore (NUS Dentistry), the National University Centre for Oral Health, Singapore (NUCOHS) and the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) to support early identification of caries risk and timely parental action.

08 Apr 2026

The wearable ring on your finger could help assess your cardiovascular health while you sleep

Consumer wearables have become everyday tools for monitoring sleep and physical activity. Researchers at the Centre for Sleep and Cognition at the NUS Yong Loo Lin School of Medicine (NUS Medicine) have now shown that their capabilities may extend further: pulse signals recorded overnight carry enough information to estimate vascular age, a key indicator of cardiovascular health.

04 Apr 2026

New MOH–NUS Fellowship launched to strengthen everyday ethics in Singapore’s healthcare sector

The inaugural Fellowship—awarded to NUH nurse Kwek Shi Qi—equips experienced healthcare professionals to translate ethical principles into everyday clinical decisions through rigorous study and real-world attachments

25 Mar 2026

International researchers develop practical recommendations to strengthen cancer microbiome research

An international team led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and A*STAR Genome Institute of Singapore (A*STAR GIS), has published a new paper in Nature Cancer highlighting the importance of greater care, consistency, and rigour in studies reporting microbes in human tumours.

23 Mar 2026

Caffeine helps restore memory function after sleep loss, NUS Medicine study shows

Researchers at NUS Yong Loo Lin School of Medicine have shown that caffeine can restore social memory impaired by sleep deprivation by acting on a specific brain circuit. The findings provide new insights into how sleep loss affects memory-related brain pathways and may inform future strategies to address cognitive impairment.

18 Mar 2026

NUS Medicine researchers create AI-guided gene-editing tool for more precise and safer DNA correction

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base editors, which enable smaller, more precise DNA correction tools that may be safer for future gene therapies.

17 Mar 2026

Maternal Mental Wellbeing shapes Children’s Early Cognitive Development, GUSTO Study finds

Singapore study finds that absence of anxiety or depressive symptoms in mothers does not necessarily indicate wellbeing, and positive maternal wellbeing is linked to stronger cognitive development in preschool children.

10 Mar 2026

Singapore sees increase in breast cancer cases but fewer deaths

A new analysis from the Global Burden of Disease (GBD) Study, published in The Lancet Oncology, projects that global breast cancer cases will rise by onethird, from 2.3 million in 2023 to more than 3.5 million in 2050. Annual deaths are expected to increase from 764,000 in 2023 to nearly 1.4 million in 2050, with the heaviest toll falling on lower-resource countries.

02 Mar 2026

NUS Medicine-Monash study: Intranasal vaccine booster shows stronger immune response and protection against sarbecoviruses

Researchers at the NUS Yong Loo Lin School of Medicine and Monash University have developed a vaccine booster candidate administered via the nasal route, which confers strong immunity in the respiratory tract. The study offers a promising strategy to enhance immunity and inform future booster approaches.